Platelet activation by collagen is increased in retinal vein occlusion

Thromb Haemost. 2007 Feb;97(2):218-27.

Abstract

Retinal vein occlusion (RVO) is the most common retinal vascular disorder second to diabetic retinopathy. The main risk factors in patients with RVO are hypertension, diabetes, hyperlipidemia, increased blood viscosity and glaucoma. The pathogenesis of RVO has not yet been clarified. In these events platelets could play a very important role. In the present study the platelet response to collagen was deeply investigated. Experiments were carried out on a selected group of RVO patients, which were compared to a group of healthy subjects matched for age, sex, clinical and metabolic characteristics. In resting and activated platelets of both groups of subjects p72syk phosphorylation, phospholipase Cgamma2 phosphorylation, protein kinase C activation, intra-cellular calcium levels and nitric oxide formation were measured. Results show that platelets of patients were more responsive to collagen or ADP than healthy subjects and that the response was significantly different (p < 0.0005) at low concentrations of these agonists. In platelets of patients stimulated with collagen increased phosphorylation of p72syk and phospholipase Cgamma2 was found. Also protein kinase C was more activated in patients. In addition intracellular calcium rise induced by collagen was significantly higher in patients than in healthy subjects. RVO patients showed a lower basal level of nitric oxide both in resting and stimulated platelets compared to healthy subjects. Altogether these results suggest that the platelet hyperaggregability described in patients might be an important factor in the development of RVO contributing to the thrombogenic effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Diphosphate
  • Aged
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Calcium / metabolism
  • Case-Control Studies
  • Collagen / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Male
  • Middle Aged
  • Nitric Oxide / metabolism
  • Phospholipase C gamma / metabolism
  • Phosphorylation
  • Platelet Activation / drug effects*
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Function Tests
  • Protein Kinase C / metabolism
  • Protein-Tyrosine Kinases / metabolism
  • Retinal Vein Occlusion / blood*
  • Retinal Vein Occlusion / drug therapy
  • Retinal Vein Occlusion / metabolism
  • Syk Kinase
  • Time Factors

Substances

  • Intracellular Signaling Peptides and Proteins
  • Platelet Aggregation Inhibitors
  • Nitric Oxide
  • Adenosine Diphosphate
  • Collagen
  • Protein-Tyrosine Kinases
  • SYK protein, human
  • Syk Kinase
  • Protein Kinase C
  • Phospholipase C gamma
  • Calcium